HMCC Completes Add-On Investment in CareAbout
Amsterdam, 9th of October 2025 – HMCC, a portfolio company of Holland Capital, proudly announces the successful completion of an add-on investment in CareAbout. This step brings together two strong organizations, joining forces to further support healthcare providers in ensuring continuity of care.
Joining forces
For many years, HMCC has been an innovative medical contact center, supporting general practitioners, pharmacies, and clinics remotely. By adding CareAbout to the group, the two companies can take significant steps together to enhance support for GP practices, pharmacies, and clinics across the Netherlands — both on-site and remotely.
Patrick Eliasar, CEO of HMCC, said: “This partnership enables us to serve our clients even better. By joining forces with CareAbout, we not only broaden our range of services, but also strengthen our team and our shared mission to ensure continuity of care.”
Timothy Hoolhorts, CEO of CareAbout, added: “We are very excited to take this step together with HMCC. This partnership allows us to expand our services and support healthcare organizations more comprehensively — from communication services to staffing solutions.”
Sterre Witteveen, Investment Manager at Holland Capital, commented: “We are impressed by the strong performance of both companies and see great added value in their combination. This partnership aligns perfectly with our broad healthcare portfolio, in which we consistently invest in innovative companies that improve the quality and accessibility of care.”
About HMCC
HMCC specializes in delivering remote healthcare services. The company supports pharmacies, GP practices, and clinics with experienced remote medical assistants, pharmacy assistants, and nurses. HMCC’s services ensure optimal accessibility, efficient workflows, and continuity of care.
About CareAbout
CareAbout recruits and places healthcare professionals with GP practices, pharmacies, and other primary care organizations. It offers both flexible and permanent placements, with personal guidance and professional development opportunities for its healthcare providers.
About Holland Capital
Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and fosters an open, sustainable, and professional relationship with the management teams of the invested companies, aiming for mutual growth. With offices in Amsterdam and Düsseldorf, Holland Capital focuses on Healthcare and Technology sector. The company has been actively supporting HMCC in its operational and strategic development since joining as a shareholder in 2023.
Yenlo and Fides join forces
Amsterdam, 21 September 2020 – Our portfolio company Yenlo (the integration specialist in the field of API and ESB technology) and Fides (the AFAS migration and integration partner for healthcare and education) join forces to support the integration for customers with...
Holland Capital invests in innovative primary care IT platform HealthConnected
Amsterdam/Alkmaar, September 1st, 2020 – Holland Capital, a Dutch based investment firm, invests in HealthConnected, a healthcare IT platform for the primary care market. This investment enables HealthConnected to focus on the expansion to new regions in the...
Holland Capital investeert in innovatief eerstelijns IT-zorgplatform HealthConnected
Amsterdam/Alkmaar, 1 september 2020 - Participatiemaatschappij Holland Capital investeert in HealthConnected, een IT-zorgplatform voor eerstelijnszorg. Met de investering richt HealthConnected zich op de uitrol naar nieuwe regio’s in Nederland en de verdere...
Sirius Medical haalt EUR 4,4 miljoen op om Sirius Pintuition te lanceren
Sirius Medical haalt EUR 4,4 miljoen op om Sirius Pintuition te lancerenEen innovatieve borstkanker lokalisatie technologie Amsterdam, 14 juli 2020 – Participatiemaatschappij Holland Capital investeert samen met BOM Brabant Ventures en Curie Capital 4,4 miljoen euro...
Sirius Medical raises €4.4M to launch Sirius Pintuition
Sirius Medical raises €4.4M to launch Sirius PintuitionAn innovative breast cancer localization technology Amsterdam, July 14th, 2020 – Investment company Holland Capital invests 4.4 million euros in Sirius Medical together with BOM Brabant Ventures and Curie Capital....
Investeren in Coronatijd: Hubert Verbeek aan het woord
Interview met Hubert Verbeek door Jos Schelfhout van Navigator Network Executive Search. Originele bron. Hubert Verbeek: ‘best practices’ helpt de bedrijven in ons portfolio Een rondje langs investeerders. Met hen bespreken we de huidige ‘Corona-tijd’; hoe kijken zij...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl